3

OWNERSHIP DOCUMENT

Company: Viridian Therapeutics, Inc.\DE
Filed: December 17, 2020
Period of Report: December 7, 2020
Accession Number: 0001104659-20-136892

View Document ↗ View on SEC.gov ↗